the design and use of iron ( iii ) chelates in the oral treatment of iron-deficiency anemia is discussed in terms of the following criteria : ( 1 ) the ability of a chelate to exist as a monomeric species even at physiological ph values , ( 2 ) the rate of transfer of iron from the chelate to the iron-transporting protein-apotransferrin , ( 3 ) the rate of depolymerization of ferric citrate polymer by the free ligand , and ( 4 ) its nontoxicity and ability to regenerate hemoglobin levels in anemic rats .
C0302583
iron
C0060231
ferric citrate